Archives

by in
Entry Author Date Location
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial 01/27/09 Boston
Synta Gets $25M From Glaxo For Cancer Drug Milestone 10/14/08 Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial 06/01/08 Boston
Page 2 of 2 « previous page
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.